Tempest Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Tempest Therapeutics

12/08/2021 22:03

* Tempest Therapeutics Inc  TPST.OQ  reported a quarterly
adjusted loss of $7.63​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of 87 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Tempest Therapeutics Inc's reported EPS for the quarter was a
loss of $7.63​.
* The mean earnings estimate of analysts had risen by
about 83.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Tempest Therapeutics Inc shares had risen by 23.0% this
quarter and lost 57.2% so far this year.
* The company reported a quarterly loss of $7.06 million.
* Wall Street's median 12-month price target for Tempest
Therapeutics Inc is $37.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:03 p.m.  ​All
figures in US dollars unless otherwise stated